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Abstract
Yersiniae enterocolitica, a gram negative rod-like organism, causes terminal ileitis and mesenteric adenitis in adolescents and adults. Some 
forms present with liver and spleen abscesses and have worse prognosis.
We report a type 1 diabetic patient with a liver abscess mimicking metastatic liver disease who was successfully treated with percutane-
ous drainage and antibiotic administration; culture from blood was positive for Yersinia enterocolitica, but drainage material from the liver 
abscess did not yield a positive result for Yersinia enterocolitica. Although the prognosis is not good in such cases, with high mortality rates, 
our patient recovered from the disease with appropriate treatment. (Pol J Endocrinol 2011; 62 (4): 357–360)
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Streszczenie
Gram-ujemna pałeczka Yersiniae enterocolitica powoduje zapalenie końcowego odcinka jelita cienkiego i zapalenie węzłów chłonnych 
krezki u młodzieży i dorosłych. Czasami obserwuje się przypadki ropni wątroby lub śledziony, które wiążą się z gorszym rokowaniem.
Autorzy opisują przypadek chorego na cukrzycę typu 1 z ropniem wątroby imitującym guz przerzutowy wątroby, u którego zastosowano 
skuteczne leczenie obejmujące drenaż przezskórny i antybiotykoterapię. W posiewie krwi wyhodowano Yersinia Enterocolitica, jednak z treści 
uzyskanej w wyniku drenażu ropnia nie uzyskano potwierdzenia obecności tych bakterii. Mimo że w takich przypadkach rokowanie jest 
niepomyślne i notuje się wysoki odsetek zgonów, dzięki odpowiedniemu leczeniu  pacjent powrócił do zdrowia.
(Endokrynol Pol 2011; 62 (4): 357–360)
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Introduction
Yersinia enterocolitica (YE) is a gram negative rod-like 
organism which causes an infection that presents itself 
in different clinical forms in children, adolescents and 
adults and is generally associated with predisposing 
factors like cirrhosis and haemochromatosis. While 
the adult form can be seen with erythema nodosum, 
polyarthritis and Reiter’s syndrome, it may also present 
itself with liver and spleen abscesses which have 
a poor prognosis [1]. Most cases are sporadic. Multiple 
serotypes from sporadic cases have been isolated and 
serotype O:8 has been reported most commonly. The 
true prevalence rate of Yersinia enterocolitica infection 
is not known, but a study has reported it as 2.8% [1]. 
Fatality rates of 34–50% have been reported in cases of 
bacteriemia, death is not frequently encountered. The 
incidence is equal among males and females. Several se-
rologic methods like tube agglutination, enzyme-linked 
immunosorbent assay and radioimmunoassay have 
been used for diagnosis. When cultures do not yield 
positive results for YE, serologic tests should be inter-
preted carefully. It must be kept in mind that antibodies 
can remain positive for years and antibody titres should 
be followed. Agglutinin levels which rise 1–2 weeks after 
infection and peak at up to 1:1,200 may be diagnostic. 
When an abscess is detected, surgical drainage and ap-
propriate antibiotic therapy is necessary. Patients should 
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be kept under observation for signs of septicemia, and 
supportive measures should be taken.
Case report
A 34 year-old male patient was admitted to our clinic 
complaining of fever, nausea, vomiting and chills of six 
weeks’ duration. Sweating, palpitations, poor appetite 
and loss of 10 kg of body weight were also noted. He 
had had type 1 diabetes mellitus (DM) for 11 years, 
which was well controlled with intensive multiple 
daily insulin injections (regular insulin three times and 
glargin insulin); his haemoglobin A1c level was 7.1. 
He had background retinopathy and neuropathy. He 
had no history of travel, exposure to animals, medical 
invasive procedures, or ingestion of contaminated food, 
water or milk.
On physical examination, he was conscious, coop-
erated and oriented with a body temperature of 38.5, 
pulse rate of 96 bpm, and blood pressure of 100/70 mm 
Hg. (BMI: 21 kg/m2). Breath sounds were coarse on 
auscultation and decreased in the right base with dull-
ness on percussion.
Abdominal examination revealed widespread ten-
derness by palpation without defence or rebound. The 
rest of the physical examination was normal. Blood 
tests showed mean fasting glucose levels 138 (70–105) 
mg/dl, glucose levels two hours post-prandially 165 mg/ 
dl, BUN 21 mg/dl, creatinin 1.4 (normal: 0.5–1.3) mg/dl, 
aspartate aminotransferase (AST) 423 (normal: 5–34) 
U/L, alanine aminotransferase (ALT) 158 (normal: 0–55) 
U/L, alkaline phosphatase (ALP) 561 (normal: 40–150) 
U/L, gamma-glutamyl transpeptidase 264 (normal: 
9–36) U/L, lactate dehydrogenase 861 (normal: 125–243) 
U/L, albumin 4.3 g/dl, globulin 4.5 (normal: 2.2–3.5) 
g/dl, potassium (K) 5.8 mmol/L, calcium 8 (normal: 
8.4–10) mg/dl, phosphorus 6.2 (normal: 3–4.5) mg/dl, 
alpha-fetoprotein (AFP) 3.18 (normal: 0.0–9.0) ng/ml, 
carcinoembryonic antigen (CEA) 1.89 (normal: 0.0–4) 
ng/ml, C-reactive protein (CRP) 149 (normal: < 0.8) 
mg/L, leukocyte 38,480/mm3, platelet 388.000/mm3, 
erythrocyte 405 × 10,000/mm3, haemoglobin 9.4 g/dl, 
haematocrit 37,2%, international normalised ratio (INR) 
1.22, and aPTT 46.5 seconds.
Gastroscopy was performed to evaluate any ma-
lignancy, and histopathology of the biopsy material 
showed chronic active gastritis without any evidence of 
malignant disease. High Resolution Computed Tomog-
raphy (HRCT) of the thorax showed a massive pleural 
effusion at the right hemithorax extending to the major 
fissure and parenchymal atelectatic areas. Thoracentesis 
was undertaken and analysis of the pleural effusion 
showed only neutrophile, macrophage and mesothelial 
cells without any atypical cells. There was no pathologi-
cal finding in bone scintigraphy.
Portal system colour Doppler ultrasonography 
revealed a blunt liver contour with an increase in size 
and detected a hypoechoic mass lesion measuring 
153 × 110 mm at the right posterior lobe of the liver, 
showing internal septations and indentations into the 
liver parenchyme, in some parts not well discriminated 
from the adjacent normal liver. These findings were 
consistent with liver abscess.
MR showed a mass lesion located at the 7th and 8th 
segments of the liver, which had a multiloculated ap-
pearance with internal septations; the largest diameter 
of the lesion was 6 cm. The lesion had decreased signal 
intensity compared with that of liver parenchyma on 
T1-weighted images and increased signal intensity on 
T2-weighted images (Figure 1). The lesion revealed 
homogeneous rim enhancement on postgadolinium 
images without any solid enhancement, which was 
strongly suggestive of liver abscess (Figure 2). Perihe-
patic and perisplenic fluid was also noted on images.
The patient underwent a whole body Fluorine-18 
fluorodeoxyglucose (F-18 FDG) positron emission to-
mography (PET)/CT (F-18 FDG-PET/CT) scan to rule 
out any possible malignancy. After ten hours of fasting, 
and having serum glucose 137 mg/dl, the patient was 
injected with 481 MBq (13 mCi) of F-18 FDG intrave-
nously. After 50 minutes of waiting in a semi-reclined 
chair, the patient was imaged using an integrated 
PET/CT scanner which consisted of a full-ring HI-REZ 
LSO PET and a 6-slice CT (Siemens Biograph 6, Chicago, 
IL, USA). The CT portion of the study was done without 
an iv contrast medium, just for defining anatomical 
landmarks and making attenuation correction on PET 
images. F-18 FDG-PET/CT images of the liver showed 
an area of minimally increased F-18 FDG uptake with 
hypometabolic regions in it, corresponding to a mass 
lesion with septations in CT (Figure 3). Blood culture 
demonstrated the presence of Yersinia enterocolitica. 
Piperacillin/tazobactam (3 × 13.5 gr/day) therapy 
was initiated before the planned abscess drainage. On 
the fourth day of antibiotherapy, after the patient’s fever 
had subsided and blood sugar levels had become stable, 
percutaneous drainage was performed. After drainage, 
the patient was discharged and further treated with 
tavanic 1 × 1 (500 gr/day/po) for an additional ten days 
as an outpatient.
Discussion
Given the gradual rise in the number of cases with YE, 
the fall in mortality rates due to development of new 
antibiotics, and the difficulty of distinguishing from 
metastatic lesions, diagnosing abscesses due to YE using 
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Figure 1. A mass lesion located at 7th and 8th segments 
of the liver with a multiloculated appearence with internal 
septations
Rycina 1. W 7 i 8 segmencie wątroby widoczna jest zmiana 
o charakterze guza o budowie wielokomorowej z przegrodami 
wewnętrznymi
Figure 2. The lesion revealed homogeneous rim enhancement 
on postgadolinium images without any solid enhancement. 
Perihepatic fluid was also noted
Rycina 2. Jednorodna zmiana o wzmocnionym obrazie otoczki na 
obrazie po podaniu gadolinium bez wzmocnienia masy. Widoczny 
płyn okołowątrobowy
Figure 3. Positron emission tomography (PET)/computerized tomography (CT) images of the liver showed an area of minimally increased 
F-18 FDG uptake with hypometabolic regions in it, corresponding to a mass lesion with septations in CT
Rycina 3. Obrazy pozytronowej tomografii emisyjnej (PET)/tomografii komputerowej (CT) wątroby wykazały obszar minimalnie 
zwiększonego wychwytu F-18 FDG z fragmentami  o zmniejszonym metabolizmie odpowiadający zmianie guzowej z przegrodami w CT
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laboratory tests and imaging modalities has growing 
importance. In a review of the literature, we found 
that nearly 50 cases have been reported with hepatic 
abscess secondary to YE [2–5]. One study showed that 
45 cases of hepatic abscess secondary to YE have been 
registered. Of the 45 reported cases, 64% had underlying 
haemochromatosis and 29% had diabetes mellitus. The 
overall mortality was 31%. Mortality prior to 1987 was 
60% (n = 20); since 1987, it has been 8% (n = 25) [2].
While investigating the multiple noncharacteristic 
lesions in the liver and distinguishing between an ab-
scess and neoplastic disease is the issue, metastasis from 
colon carcinoma, ovarian carcinoma, lung carcinoma, 
carcinoid tumours, malignant melanoma and sarcomas 
are among possible reasons. The MRI images of the 
foci of fungal abscesses usually present as multiple foci 
of lesions less than 1 cm in diameter. There are often 
coexisting lesions in the spleen [6–12]. Our patient’s 
MRI images showed a lesion with irregular, heterog-
enous and gradually increasing contrast enhancement 
circumferentially and peripheric oedema, rather than 
early uptake and following wash-out. Imaging and 
clinical findings were consistent with abscess rather 
than malignancy or metastasis.
F-18 FDG PET/CT imaging has been well accepted 
in oncology as an effective modality in the diagnosis, 
staging, restaging and therapy response evaluation for 
a variety of malignancies. F-18 FDG accumulates in 
cancer cells due to an increased glucose metabolism of 
the cancer cells, but it is not a tumour-specific agent. F-18 
FDG is also known to accumulate in inflammatory cells 
infiltrating various inflammatory and infectious lesions, 
such as lymphocytes, neutrophils, and macrophages, 
which have elevated glucose requirements [13, 14]. FDG 
uptake by infectious and inflammatory lesions may also 
cause false-positive results by resembling metastases 
when exploring the metastatic sites in cancer patients. It 
is important to be aware of this pitfall when interpret-
ing PET/CT images in patients with malignant diseases.
The cases reported in the literature have mostly 
been associated with immune deficiency and unregu-
lated DM [15–17]. In our case, HbA1c, fasting blood 
sugar and postprandial blood sugar levels showed 
that it was a well controlled DM case without any 
findings which would raise suspicion of ketoacidosis 
on admission. The patient’s serum iron, iron binding 
capacity and ferritin levels were normal, ruling out 
any predisposing iron overload due to diseases like 
haemochromatosis. When the initial symptoms are 
taken into account, the patient was supposed to have 
been infected via the alimentary tract.
Mortality rates due to YE are decreasing with the 
development of new antibiotics. Following parenteral 
and oral antibiotherapy, together with percutaneous 
drainage of the abscess, the symptoms of the patient 
improved and recovery in the general status of the 
patient was observed. Insulin and fluid replacement 
was done since the course of the blood glucose levels 
of the patient was labile.
It should be kept in mind that even if it is well con-
trolled, DM is a predisposing condition for infections, 
and glycaemic regulation might also be disturbed be-
cause of infection.
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